Biotech BioNxt Reports “Intention to Grant” Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies November 4, 2025
Biotech BioNxt Reports “Readiness to Grant” Patent Notification from the Eurasian Patent Organization October 30, 2025
Featured News BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug October 22, 2025
Biotech BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study October 21, 2025
Featured News Wisp & Vesalius Forge Women-Centric Longevity Path With Peptide Therapy Launch October 17, 2025
Search
biotechnology
February 4, 2026
February 3, 2026
February 3, 2026
January 28, 2026
November 4, 2025
October 30, 2025
October 29, 2025
October 22, 2025
October 21, 2025
October 17, 2025
